Johnson N, Bentley J, Wang LZ, Newell DR, et al. Editorial Expression of Concern: Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. Br J Cancer 2024 Aug 19. doi: 10.1038/s41416-024-02813.
PMID: 39160248